Bioretec Ltd (BRETEC) - Product Pipeline Analysis, 2025 Update

Summary

Bioretec Ltd (Bioretec), formerly BCI Bioabsorbable Concepts Oy is a medical device company that develops, manufactures and distributes bioabsorbable, bioactive and drug releasing surgical implants. The company’s products include activa IM nail, activanail, activapin, activascrew, activascrew cannulated, activascrew interference, activascrew interference TCP, remeos screw. Its activascrew is designed to restore the original load carrying capacity of the bone. Bioretec also offers instrument sets and separate parts and equipment for its products. It markets its products under the brands such as ActivaScrew, ActivaNail, ActivaPin, CiproScrew. It uses bone fixation device technology to manufacture its products. The company operates development and manufacturing facilities in Tampere. Bioretec is headquartered in Tampere, Finland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Bioretec Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Bioretec Ltd Company Overview
Bioretec Ltd Company Snapshot
Bioretec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Bioretec Ltd – Pipeline Analysis Overview
Bioretec Ltd - Key Facts
Bioretec Ltd - Major Products and Services
Bioretec Ltd Pipeline Products by Development Stage
Bioretec Ltd Ongoing Clinical Trials by Trial Status
Bioretec Ltd Pipeline Products Overview
Activa Single-Use Instrumentation Set
Activa Single-Use Instrumentation Set Product Overview
Bioabsorbable Sternotomy Fixation Device
Bioabsorbable Sternotomy Fixation Device Product Overview
RemeOs DrillPin
RemeOs DrillPin Product Overview
RemeOs DrillPin Clinical Trial
RemeOs IM-Nail
RemeOs IM-Nail Product Overview
RemeOs Single-Use Instrumentation Set
RemeOs Single-Use Instrumentation Set Product Overview
RemeOs Spinal Interbody Cage
RemeOs Spinal Interbody Cage Product Overview
Spinal Plate - Spinal Osteosynthesis
Spinal Plate - Spinal Osteosynthesis Product Overview
Bioretec Ltd - Key Competitors
Bioretec Ltd - Key Employees
Bioretec Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Bioretec Ltd, Recent Developments
Feb 14, 2025: CE Mark Approval for RemeOs Trauma Screw Product Group, Featuring Four Product Lines With Over 200 Individual Products, Drives Global Expansion for Bioretec
Nov 22, 2024: Bioretec Signed a New Sales and Distribution Agreement to Accelerate the Commercialization of Remeos Trauma Screw in the U.S. Civilian Hospital Market
Oct 04, 2024: Inside Information: Bioretec Updates Its Product Development Strategy by Accelerating the Product Development of RemeOs Spinal Interbody Cage
Jun 27, 2024: Update for Bioretec's RemeOs Trauma Screw European Marketing Authorization
Jun 19, 2024: Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs trauma screw: fracture healing confirmed in 100% of surgical procedures
Mar 22, 2024: Patent allowed for Bioretec’s RemeOs alloy in US
Mar 14, 2024: Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs Spinal Interbody Cage
Mar 08, 2024: Bioretec’s European Market Authorization for Remeos Trauma Screw Has Proceeded to Expert Panel Evaluation, the Approval Is Estimated During the Q2 2024
Oct 18, 2023: Bioretec Estimates that the Approval of the European market Authorization for the biodegradable RemeOs Trauma Screw Will Move to the First Quarter of 2024
Sep 12, 2023: Inside information: Bioretec Enters into the U.S. Distribution Agreement with Spartan Medical for the RemeOs Screws
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Bioretec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Bioretec Ltd Pipeline Products by Equipment Type
Bioretec Ltd Pipeline Products by Indication
Bioretec Ltd Ongoing Clinical Trials by Trial Status
Bioretec Ltd, Key Facts
Bioretec Ltd, Major Products and Services
Bioretec Ltd Number of Pipeline Products by Development Stage
Bioretec Ltd Pipeline Products Summary by Development Stage
Bioretec Ltd Ongoing Clinical Trials by Trial Status
Bioretec Ltd Ongoing Clinical Trials Summary
Activa Single-Use Instrumentation Set - Product Status
Activa Single-Use Instrumentation Set - Product Description
Bioabsorbable Sternotomy Fixation Device - Product Status
Bioabsorbable Sternotomy Fixation Device - Product Description
RemeOs DrillPin - Product Status
RemeOs DrillPin - Product Description
RemeOs DrillPin - To Evaluate the Feasibility of the Clinical Application of Mg-based RemeOs™ DrillPin for Fixation of Fractures of the Distal Radius in Children From the Age of Over 5 and Under 14.
RemeOs IM-Nail - Product Status
RemeOs IM-Nail - Product Description
RemeOs Single-Use Instrumentation Set - Product Status
RemeOs Single-Use Instrumentation Set - Product Description
RemeOs Spinal Interbody Cage - Product Status
RemeOs Spinal Interbody Cage - Product Description
Spinal Plate - Spinal Osteosynthesis - Product Status
Spinal Plate - Spinal Osteosynthesis - Product Description
Bioretec Ltd, Key Employees
Glossary
List of Figures
Bioretec Ltd Pipeline Products by Equipment Type
Bioretec Ltd Pipeline Products by Development Stage
Bioretec Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings